Obesity is a multifactorial global epidemic with associated risk
factors for an array of vascular, metabolic, psychological and
economical consequences. Bariatric surgery has revealed a
significant link between gastrointestinal metabolism and obesity
that extends to resolution of many metabolic diseases including
type 2 diabetes and cardiovascular disease risk. Bariatric surgery
offers the most effective results and Roux-en Y gastric bypass
(RYGB) is the most commonly performed bariatric surgery worldwide.
The effective weight loss achieved by RYGB is thought to be caused
by the re-arrangement of the gastrointestinal tract leading
malabsorption and restriction of the ingested nutrients, and
consequently resulting in alterations in the gut hormone levels.
The first chapter of this book briefly summarises the current
literature on the changes in the gastrointestinal hormones
following RYGB. Chapter Two studies the role of bariatric surgery
in the resolution of obesity and type 2 diabetes. Chapter Three
discusses how to treat a type 2 diabetes patient post-bariatric
surgery. The last chapter discusses the recent findings of the
relationship between gastric bypass and four different skin
disorders.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!